Efficacy of abrocitinib monotherapy for the treatment of moderate-to-severe atopic dermatitis by race

被引：0

作者：

Alexis, A. F. ^{[1
]}

Silverberg, J. I. ^{[2
]}

Rice, Z. P. ^{[3
]}

Armstrong, A. W. ^{[4
]}

Desai, S. R. ^{[5
,6
]}

Fonacier, L. ^{[7
]}

Kabashima, K. ^{[8
]}

Levenberg, M. ^{[9
]}

Biswas, P. ^{[9
]}

Cella, R. Rojo ^{[10
]}

Chan, G. L. ^{[10
]}

机构：

[1] Weill Cornell Med Coll, New York, NY USA

[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA

[3] Dermatol Associates Georgia, Atlanta, GA USA

[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA

[5] Innovat Dermatol, Plano, TX USA

[6] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[7] NYU Langone Hosp Long Isl, Mineola, NY USA

[8] Kyoto Univ, Kyoto, Japan

[9] Pfizer Inc, New York, NY USA

[10] Pfizer Inc, Groton, CT 06340 USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

516

引用

页码：E137 / E138

页数：2

共 50 条

[21] Efficacy and safety of abrocitinib in adolescents with moderate-to-severe atopic dermatitis from the JADE clinical trial programme
Eichenfield, L. F.
Flohr, C.
Bangert, C.
Irvine, A. D.
Weidinger, S.
Nesnas, J.
Koppensteiner, H.
Zhang, F.
Rojo, R.
Chan, G.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E142 - E143
[22] Efficacy of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis using treat-to-target goals
De Bruin-Weller, M.
Weidinger, S.
Gooderham, M.
Pink, A.
Silverberg, J.
DiBonaventura, M.
Kerkmann, U.
Lazariciu, I.
Clibborn, C.
BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E171 - E171
[23] Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis
Staumont-Salle, Delphine
Barbarot, Sebastien
Bouaziz, Jean David
Chan, Chan
Clibborn, Claire
Du-Thanh, Aurelie
Feeney, Claire
Lejeune, Alexandre
Misery, Laurent
Nosbaum, Audrey
Seneschal, Julien
Soria, Angele
Zhang, Fan
JEADV CLINICAL PRACTICE, 2023, 2 (03): : 518 - 530
[24] Dupilumab in the treatment of moderate-to-severe atopic dermatitis
Kraft, Magdalena
Worm, Margitta
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) : 301 - 310
[25] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
Zheng, Y.
BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
[26] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
Khattri, Saakshi
Brunner, Patrick M.
Garcet, Sandra
Finney, Robert
Cohen, Steven R.
Oliva, Margeaux
Dutt, Riana
Fuentes-Duculan, Judilyn
Zheng, Xiuzhong
Li, Xuan
Bonifacio, Kathleen M.
Kunjravia, Norma
Coats, Israel
Cueto, Inna
Gilleaudeau, Patricia
Sullivan-Whalen, Mary
Suarez-Farinas, Mayte
Krueger, James G.
Guttman-Yassky, Emma
EXPERIMENTAL DERMATOLOGY, 2017, 26 (01) : 28 - 35
[27] Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
Bridgeman, Sarah G.
Martino, Anna K.
Strowd, Lindsay C.
EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2153 - 2159
[28] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
Xu, Xinghua
Zheng, Yi
Zhang, Xin
He, Yanling
Li, Chengxin
ONCOTARGET, 2017, 8 (65) : 108480 - 108491
[29] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
Khattri, S.
Brunner, P. M.
Garcet, S.
Finney, R.
Cohen, S. R.
Oliva, M.
Dutt, R.
Fuentes-Duculan, J.
Zheng, X.
Li, X.
Bonifacio, K. M.
Kunjravia, N.
Coats, I.
Cueto, I.
Gilleaudeau, P.
Sullivan-Whalen, M.
Suarez-Farinas, M.
Krueger, J. G.
Guttman-Yassky, E.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S41 - S41
[30] Efficacy and safety of 611 for the treatment of moderate-to-severe atopic dermatitis in adults
Zhang, Jianzhong
Zhao, Yan
Zhou, Qinghong
Xu, Yuyu
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I54 - I55

← 1 2 3 4 5 →